Active, not recruiting
Phase II Study of IMC-A12 in Patients With Mesothelioma Who Have Been Previously Treated With Chemotherapy
|2||Active, not recruiting||
Combination of Gemcitabine and Imatinib Mesylate in Pemetrexed-pretreated Patients With Pleural Mesothelioma
Autologous Dendritic Cell Vaccination in Mesothelioma
|4||Active, not recruiting||
Response Evaluation in Malignant Pleural Mesothelioma
† Study has passed its completion date and status has not been verified in more than two years.